发明名称 Poly (ADP-ribose) polymerase inhibitor
摘要 Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.
申请公布号 US9187430(B2) 申请公布日期 2015.11.17
申请号 US201214361698 申请日期 2012.12.03
申请人 CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD. 发明人 Ji Jianxin;Guo Na;Xue Ting;Kang Bingqiang;Ye Xinfa;Chen Xin;Zhang Tao
分类号 C07D237/32;C07D401/14;C07D413/14;A61K31/502;A61K31/5025;C07D401/12;C07D407/14;C07D409/14;C07D417/14 主分类号 C07D237/32
代理机构 Jun He Law Offices P.C. 代理人 Jun He Law Offices P.C. ;Zhu James J.
主权项 1. The compound 4-(3-(4-(1-(dimethylamino)cyclopropanecarbonyl) piperazine-1-carbonyl)-4-fluorophenoxy)2H-phthalazin-1-one, pharmaceutically acceptable salt or stereoisomer thereof.
地址 High-Tech Devlopment Zone, Chengdu CN